Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat for Metabolic Syndrome Features in Gout
NCT01654276Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- May 2012
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of febuxostat in metabolic syndrome, sponsored by UT Southwestern Medical Center. Started May 2012; status: completed.
02
Drugs
febuxostat
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT01654276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654276.